Feasibility and Impact of an Evidence-based Electronic Decision Support System on Diabetes Care in Family Medicine: a Cluster Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- KU Leuven
- 入组人数
- 45
- 试验地点
- 1
- 主要终点
- Pre- to post-implementation change in HbA1c.
研究概览
简要总结
The purpose of this study is to assess the feasibility of the use of an evidence-based decision support system (EBMeDS) in daily Belgian family medicine and to study the effectiveness of EBMeDS use on improving diabetes care.
详细描述
The purpose of this study is to assess the feasibility of the use of an evidence-based decision support system (EBMeDS) in daily Belgian family medicine and to study the effectiveness of EBMeDS use on improving diabetes care.
Specific research questions are:
- Does family physicians use the EBMeDS system in daily practice?
- Does the use of the EBMeDS system by family physicians leads to an improvement in diabetes control compared to the control group?
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients are 18 years or older.
- •Patients have their electronic medical records registered by one of the included family physicians. Medical records are not centralized in Belgium. Patients are free to choose any physician, and can even see several physicians at the same time. To encourage a patient to have their medical records held by a single physician, 'Global Medical Records' werr introduced a decade ago. In return for a registration fee, patients can choose a main general practitioner who keeps their central medical records. This registration is a requirement for patient inclusion in the trial. Patients with 'Global Medical Records' are reimbursed a larger proportion of the consultation fees by the health insurance fund.
- •Patients have an established diagnosis of diabetes at the baseline time point of the study (identified as having (1) an ICPC (International Classification of Primary Care) code of diabetes or (2) a prescription for a diabetes-specific or (3) the necessary labo results to confirm diabetes)
排除标准
- •Pregnancy
- •Cognitive impairment
研究组 & 干预措施
EBMeDS group
The regular Evidence Linker and the EBMeDS system will be available in this group.
干预措施: The EBMeDS system (Behavioral)
EBMeDS group
The regular Evidence Linker and the EBMeDS system will be available in this group.
干预措施: Evidence Linker (Other)
Control group
The regular Evidence Linker will be available in this group.
干预措施: Evidence Linker (Other)
结局指标
主要结局
Pre- to post-implementation change in HbA1c.
时间窗: Outcome will be collected at five points in time: before the start of the study, at 3 months, at 6 months, at 9 months and at 12 months
次要结局
- Pre- to post-implementation change in cholesterol levels.(Outcome will be collected at five points in time: before the start of the study, at 3 months, at 6 months, at 9 months and at 12 months)
- Pre- to post-implementation change in blood pressure measurements.(Outcome will be collected at five points in time: before the start of the study, at 3 months, at 6 months, at 9 months and at 12 months)
- Pre- to post-implementation change in a composite patient score.(Outcome will be collected at five points in time: before the start of the study, at 3 months, at 6 months, at 9 months and at 12 months)
- Pre- to post-implementation change in a composite process score.(Outcome will be collected at five points in time: before the start of the study, at 3 months, at 6 months, at 9 months and at 12 months)